About the NCBPNG Steering Committee
Current Team
Andrew joined the NCBPNG Steering Committee in 2017. He is a Research Scientist and founder of CoreBioPathways LLC which specializes in bioinformatics, data analysis, and laboratory efficiency consulting.
Matt joined the NCBPNG Steering Committee in 2023.
DJ joined the NCBPNG Steering Committee in 2023.
Jessica joined the steering committee in 2025.
Maddy Kelsey is an Account Manager at Dexian, where she plays a key role in supporting a broad range of specialized functions across the Life Sciences sector, including Data, Engineering, Manufacturing, Quality, PMO, IT, and Applications. With a strong foundation in client relationship management, Maddy partners with leading pharmaceutical and biotech companies to connect them with top-tier talent, while also guiding candidates towards roles that align with their skills and goals. She’s excited to be a part of NCBPNG!
Marty O’Boyle currently serves as the Head of Consulting – North America for Koerber-Pharma, which specializes in pharma engineering consulting for life science manufacturing companies. He is also the founder and president of Sandpiper Technical Solutions, a full service solutions provider for biopharma laboratory automation. Marty started his engineering career as an applications engineer specializing in pneumatic, hydraulic, and electromechanical design. In 1999, he joined Klockner-Medipak Inc, in Clearwater, FL (now Koerber-Pharma) as a packaging machinery project engineer. Over a twenty-year period he fulfilled a variety of roles in service to Koerber’s clients in the life sciences market (Project Engineer, Project Manager, Validation Engineer, Technical Sales Director, and Technical Director for North American Operations). In 2019, Marty founded Sandpiper to expand into the growing field of life science automation, at the laboratory scale. Marty joined the NCBPNG Steering Committee in 2022.
Pratik joined the NCBPNG Steering Committee in 2024.
Matt Troskey is a Director of Business Development at Medicilon, a leading CRO providing fully integrated pharmaceutical R&D services for global pharma. He is passionate about pushing the boundaries of drug discovery and development, from small molecules to biologics, peptides, ADCs, cell and gene therapies. Matt’s expertise spans custom synthesis, medicinal chemistry, biology and bioanalysis, pharmacology, DMPK, PD, toxicology, CMC services, formulation, process development, and manufacturing.
At Medicilon, Matt builds powerful partnerships and delivers top-tier solutions to overcome the toughest R&D challenges. Whether it’s navigating IND-enabling studies, scaling up manufacturing, or providing regulatory support, he is committed to accelerating drug development pipelines and reducing time to market. Together, we can transform bold ideas into breakthrough therapies that change lives.